WUXI BIO (02269) issued a total of 1,505,000 shares in accordance with the pre-IPO stock option plan.
WuXi Biologics (02269) announced that on September 2, 2026, the company will issue 5,000 ordinary shares in accordance with the pre-IPO share option plan adopted by the company on January 5, 2016 (revised on August 10, 2016) for the exercise of options.
WUXI BIO (02269) announced that on September 2, 2026, the company issued 5,000 ordinary shares for the exercise of options under the pre-IPO share option plan adopted on January 5, 2016 (revised on August 10, 2016).
On September 2, 2026, the company issued 1.5 million ordinary shares for the exercise of options under the pre-IPO share option plan adopted on January 5, 2016 (revised on August 10, 2016).
Related Articles
US Stock Market Move | The concept stocks of storage chips fell broadly, with Seagate Technology Holdings PLC (STX.US) dropping 3%.
CAOCAO INC (02643) spent approximately HKD 1.3678 million on September 2 to repurchase 100,000 shares.
DL HOLDINGS GP (01709) granted a total of 66.9 million share options.
US Stock Market Move | The concept stocks of storage chips fell broadly, with Seagate Technology Holdings PLC (STX.US) dropping 3%.
CAOCAO INC (02643) spent approximately HKD 1.3678 million on September 2 to repurchase 100,000 shares.
DL HOLDINGS GP (01709) granted a total of 66.9 million share options.
RECOMMEND
